This activity will bring together clinical and research experts to review and discuss the evaluation, treatment, and prognosis of patients presenting with low back pain. The live activity will consist of three didactic lectures and a question-and-answer session to provide an in-depth and comprehensive discussion of the epidemiology, disparate etiologies, and clinical assessment of both acute and chronic low back pain. Evidence-based treatment strategies, including pharmacologic and nonpharmacologic therapies, and the evolving research into early interventions for patients at high risk for transitioning from acute low back pain to chronic low back pain will also be presented.
Learning Objectives
1. Discuss the differential diagnosis for low back pain and the importance of clinical red and yellow flags in evaluation of low back pain.
2. Integrate evidence-based pharmacologic and nonpharmacologic therapies into a comprehensive treatment plan for chronic low back pain.
3. Evaluate early interventions for acute back pain in patients considered at high risk for transition to chronic low back pain.
Faculty
B. Eliot Cole, MD MPA
Roger Chou, MD
Bill McCarberg, MD
University of California, Irvine School of Medicine is the accredited provider for this activity, in conjunction with the Purdue University School of Pharmacy and Pharmaceutical Science; University of California, Irvine, College of Health Sciences, Program in Nursing Science; and Alliant International University. This session will offer continuing education for physicians, psychologists, nurses, and pharmacists. This symposium is supported by an educational grant from Lilly USA, LLC. Participants with any questions regarding continuing education earned through participation in this symposium should contact Bonnie Carroll at bcarroll@uci.edu.